Cocooning because of the threat of COVID-19 has taken its toll on Romanians’ general health. With a smaller propensity for engaging in sports activities, many people have gained weight and developed digestive problems, due to an erratic diet.
Sanofi Romania will continue to lead digestive remedies in 2021, largely due to the strength of its No-spa and Buscopan brands in IBS treatments and the success of its Dulcolax product in laxatives. The company has been able to establish its brands as the number one choice for many loyal consumers due to its strong focus on marketing activities and the reputation that each of its brands has for efficacy.
2020 and 2021 saw consumer demand in digestive remedies continue to shift towards products with a herbal base as concerns over the side-effects of the long-term use of standard OTC digestive remedies spread, especially among affluent urban consumers, a particularly attractive consumer base for consumer health companies. This will benefit companies such as The Himalaya Drug Co, a player that trades primarily on the natural and holistic image of its products.
The COVID-19 crisis is making consumers become more mindful in regard to their health, with their diet being an area they are looking to improve. Over the forecast period, they will be likely to pay more attention to digestive remedies as they strive to ensure their digestive health is always kept under control.
With visiting a doctor to obtain a prescription a time-consuming and often expensive process, Romanian people are increasingly likely to resort to self-medication in the forecast period when experiencing digestive discomfort. This is especially the case for mild to moderate symptoms that people have experienced previously, with consumers only likely to consult a doctor if symptoms are greater or persist.
Indigestion and heartburn remedies is set to continue accounting for the highest proportion of sales in digestive remedies throughout the forecast period. Antiflatulents, including gallbladder drainers (choleretics) and digestive enzymes, are the most popular digestive remedies in Romania and this is the reason that H2 blockers and proton pump inhibitors are Rx only.
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
Understand the latest market trends and future growth opportunities for the Digestive Remedies industry in Romania with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Digestive Remedies industry in Romania, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
This report originates from Passport, our Digestive Remedies research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page